Alpine Immune Sciences, Inc. revenue breakdown overview

Alpine Immune Sciences, Inc. revenue for the last year amounted to 58.88 M USD, the most of which — 58.88 M USD — came from its highest performing source at the moment, Protein-based Immunotherapies, the year earlier bringing 30.06 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Alpine Immune Sciences, Inc. 58.88 M USD, and the year before that — 30.06 M USD.